BI
DAWN

BVF Inc’s Day One Biopharmaceuticals DAWN Stock Holding History

BVF Inc’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-809,282
Closed -$8.03M – 82
2022
Q1 		$8.03M Hold
809,282
– – 0.32% 60
2021
Q4 		$13.6M Sell
809,282
-1,002
-0.1% -$20.6K 0.49% 49
2021
Q3 		$19.2M Sell
810,284
-108,691
-12% -$2.6M 0.75% 39
2021
Q2 		$20.9M Buy
+918,975
New +$19.2M 0.78% 35

Other funds holding DAWN

CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc's DAWN Position: Q2 2022 in Review

BVF Inc sold out of Day One Biopharmaceuticals (DAWN) in Q2 2022, closing a stake of 809,282 shares — an estimated $8.03M sold.

BVF Inc first reported a position in DAWN in Q2 2021 and held it in 4 quarters. The position peaked at $20.9M in Q2 2021. 87 funds tracked by Wall St. Rank hold DAWN as of Q2 2022.

  • BVF Inc reported no remaining Day One Biopharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • BVF Inc sold 809,282 Day One Biopharmaceuticals shares in Q2 2022, an estimated $8.03M.
  • BVF Inc first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 4 quarters.
  • BVF Inc's Day One Biopharmaceuticals position peaked at $20.9M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2022.

Based on BVF Inc's 13F filing for Q2 2022, filed 15 Aug 2022.